DAX

5-BROMO-N[2-(DIMETHYLAMINO)ETHYL]-9-AMINOACRIDINE-4-CARBOXAMIDE

Created:	2002-07-22
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where DAX is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	2
Atom Count	45
Chiral Atom Count	0
Bond Count	47
Aromatic Bond Count	16

2D diagram of DAX

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	5-BROMO-N[2-(DIMETHYLAMINO)ETHYL]-9-AMINOACRIDINE-4-CARBOXAMIDE
Systematic Name (OpenEye OEToolkits)	2-[(9-amino-5-bromo-acridin-10-ium-4-yl)carbonylamino]ethyl-dimethyl-azanium
Formula	C₁₈ H₂₁ Br N₄ O
Molecular Weight	389.29
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(NCC[NH+](C)C)c1c3c(ccc1)c(c2cccc(Br)c2[nH+]3)N
SMILES	CACTVS	3.341	C[NH+](C)CCNC(=O)c1cccc2c(N)c3cccc(Br)c3[nH+]c12
SMILES	OpenEye OEToolkits	1.5.0	C[NH+](C)CCNC(=O)c1cccc2c1[nH+]c3c(c2N)cccc3Br
Canonical SMILES	CACTVS	3.341	C[NH+](C)CCNC(=O)c1cccc2c(N)c3cccc(Br)c3[nH+]c12
Canonical SMILES	OpenEye OEToolkits	1.5.0	C[NH+](C)CCNC(=O)c1cccc2c1[nH+]c3c(c2N)cccc3Br
InChI	InChI	1.03	InChI=1S/C18H19BrN4O/c1-23(2)10-9-21-18(24)13-7-3-5-11-15(20)12-6-4-8-14(19)17(12)22-16(11)13/h3-8H,9-10H2,1-2H3,(H2,20,22)(H,21,24)/p+2
InChIKey	InChI	1.03	NROQPXQSDDINMC-UHFFFAOYSA-P

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB02390
Name	5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide
Groups	experimental
Synonyms	5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide

Related Resource References

Resource Name	Reference
PubChem	447088, 4628823

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.